| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥154.7B | ¥168.0B | -7.9% |
| Operating Income | ¥22.5B | ¥31.7B | -29.0% |
| Ordinary Income | ¥24.2B | ¥32.7B | -26.2% |
| Net Income | ¥14.0B | ¥10.4B | +35.7% |
| ROE | 2.9% | 1.9% | - |
FY2026 Q1 results: Revenue 154.7B yen (YoY -7.9%), Operating Income 22.5B yen (YoY -29.0%), Ordinary Income 24.2B yen (YoY -26.2%), Net Income 14.0B yen (YoY +34.6%). The company experienced revenue decline and significant operating profit contraction in the first quarter. While net income showed growth, this improvement was primarily driven by extraordinary items, specifically 9.2B yen in gains from the sale of fixed assets. The underlying business profitability deteriorated, with operating margin compressing to 14.6% from previous levels. Despite maintaining a high gross profit margin of 68.2%, selling, general and administrative expenses weighed on operating results. Total assets decreased to 704.3B yen from 764.9B yen in the prior period, while equity declined to 480.2B yen from 542.1B yen. The company maintains its full-year forecast of 65.0B yen in revenue (up 0.4% YoY), 11.4B yen in operating income (up 2.9% YoY), and 8.2B yen in net income attributable to owners.
[Profitability] ROE of 2.8% reflects compressed profitability with net profit margin at 8.5%, total asset turnover at 0.220, and financial leverage at 1.47 times. Operating margin of 14.6% represents the EBIT margin, while gross profit margin remains robust at 68.2%. The effective tax rate reached 54.1%, indicating significant tax burden with a tax burden coefficient of 0.433. Interest burden coefficient of 1.357 suggests minimal interest expenses relative to operating earnings. The primary constraint on ROE is the low asset turnover ratio of 0.220, significantly impacted by working capital inefficiencies. Operating income to revenue ratio declined to 14.6% as SG&A expenses of 8.3B yen consumed a substantial portion of gross profit. [Cash Quality] Cash and deposits totaled 12.5B yen, representing short-term debt coverage capability. Current assets of 43.6B yen against current liabilities of 10.0B yen provide a cash conversion buffer. Working capital metrics show severe deterioration with Days Sales Outstanding at 242 days, Days Inventory Outstanding at 621 days, and Cash Conversion Cycle at 623 days, indicating substantial capital tied up in receivables and inventory. [Investment Efficiency] Total asset turnover of 0.220 reflects inefficient asset utilization. ROIC stands at 3.2%, indicating limited return on invested capital. The combination of declining sales (down 7.9% YoY) and elevated working capital balances significantly constrains capital efficiency. [Financial Health] Equity ratio of 68.2% demonstrates strong capitalization. Current ratio of 435.5% and quick ratio of 370.3% indicate robust liquidity buffers. Debt-to-equity ratio of 0.47 reflects conservative capital structure with limited leverage. Total assets of 704.3B yen are supported by equity of 480.2B yen and liabilities of 224.0B yen.
Cash and deposits decreased substantially by 144.4B yen (down 53.6%) from 269.3B yen in the prior year to 124.9B yen in the current period, representing a significant reduction in liquid resources despite maintaining high liquidity ratios. The cash decline occurred alongside a gain from fixed asset sales of 9.2B yen recorded in extraordinary income, suggesting that proceeds from asset disposals were insufficient to offset other cash outflows. Working capital efficiency deteriorated markedly, with accounts receivable standing at 10.3B yen and inventory reaching 6.6B yen. The inventory turnover cycle of 621 days and receivables collection period of 242 days indicate substantial operating capital trapped in the business cycle, restricting cash generation from operations. Current liabilities of 10.0B yen remain well-covered by current assets of 43.6B yen, providing a short-term debt coverage ratio of 4.36 times. However, the dramatic cash reduction from prior levels raises questions about fund deployment, potentially including dividend payments, working capital build-up, or other financing activities. The divergence between reported net income improvement (14.0B yen versus 10.4B yen prior year) and cash decline suggests earnings quality concerns, with profits heavily influenced by non-cash or non-recurring items. Total liabilities decreased from prior levels, indicating potential debt repayment or liability reduction activities during the quarter.
Ordinary income of 24.2B yen versus operating income of 22.5B yen shows non-operating net contribution of approximately 1.7B yen, primarily comprising financial income and gains. This non-operating income represents 1.1% of revenue, a modest contribution to overall profitability. The substantial divergence between net income of 14.0B yen and operating income of 22.5B yen stems from extraordinary items, specifically 9.2B yen in gains from fixed asset sales recorded as extraordinary income, offset by 2.9B yen in extraordinary losses including 1.2B yen in impairment losses. Extraordinary income represents approximately 66% of net income, indicating significant reliance on one-time items for reported profitability. The tax expense of 12.5B yen against pre-tax income of 23.1B yen yields an effective tax rate of 54.1%, substantially above standard corporate rates, potentially reflecting non-deductible expenses or adjustments to deferred tax assets. The composition of earnings reveals that recurring operational performance is weaker than headline net income suggests, with operating income down 29.0% YoY despite net income showing growth. The severe working capital deterioration with Days Inventory Outstanding at 621 days and Days Sales Outstanding at 242 days creates significant accruals that may not convert to cash, further questioning earnings quality. While specific operating cash flow data is not disclosed for the quarterly period, the 53.6% decline in cash balances alongside net income growth strongly suggests that reported earnings are not generating commensurate cash flows, indicating low earnings quality and high accrual content.
Working capital management represents the most critical operational risk, with Days Inventory Outstanding at 621 days and Days Sales Outstanding at 242 days creating a Cash Conversion Cycle of 623 days. This extreme capital inefficiency indicates either structural issues in inventory turnover and receivables collection, or potential product obsolescence and credit quality concerns. The prolonged cycle ties up approximately 16.9B yen in working capital that could otherwise generate returns or be returned to shareholders. Earnings sustainability risk stems from heavy dependence on extraordinary items, with fixed asset sale gains of 9.2B yen comprising approximately 66% of reported net income. Core operating profitability declined 29.0% YoY, and without continued asset sales or other non-recurring gains, earnings face significant downward pressure. The company's full-year forecast implies substantial improvement in remaining quarters, creating execution risk if operational turnaround does not materialize. Liquidity and capital allocation risk has emerged from the 53.6% decline in cash balances to 12.5B yen, while simultaneously maintaining an exceptionally high dividend commitment of 230 yen per share at fiscal year-end. Based on 34.2 million shares, this implies approximately 7.9B yen in dividend payments against net income of 13.2B yen for the quarter, suggesting an annualized payout ratio approaching 595%. This creates a fundamental mismatch between cash generation capability and shareholder return commitments, potentially requiring draws on accumulated reserves or further asset disposals to fund dividends while maintaining operational liquidity.
[Industry Position] (Reference - Proprietary Analysis) The company's operating margin of 14.6% in FY2026 Q1 reflects the business model characteristics of the cosmetics and health products sector, where premium positioning typically supports elevated margins. However, the year-over-year margin compression from prior operating margin levels indicates competitive or operational pressures. Revenue growth of negative 7.9% for the quarter contrasts with the full-year guidance of near-flat growth at positive 0.4%, suggesting either seasonal factors or planned recovery in subsequent quarters. Within the personal care and cosmetics industry, companies typically demonstrate net profit margins ranging from 5% to 15% depending on brand positioning and channel mix. The company's reported net profit margin of 9.1% falls within this range, though the quality of earnings is compromised by extraordinary items. Historical analysis shows the company maintained relatively stable profitability metrics across prior periods, with the current quarter representing notable operational deterioration. The equity ratio of 68.2% demonstrates financial conservatism well above typical industry leveraging practices, where cosmetics manufacturers often operate with equity ratios between 40% to 60%. ROE of 2.8% significantly underperforms industry norms, where established cosmetics companies typically generate ROE in the range of 8% to 15%, indicating substantial room for improvement in capital efficiency. The primary differentiating factor is the exceptionally poor working capital management, with inventory and receivables cycles substantially longer than industry standards of typically 90-180 days for inventory and 60-90 days for receivables in direct-to-consumer and wholesale cosmetics distribution models.
First, the fundamental business demonstrates structural profitability challenges masked by extraordinary items, with operating income declining 29.0% while net income grew only through 9.2B yen in asset sale gains. Core operational performance requires significant improvement to achieve full-year guidance, particularly given the first quarter represents approximately 23.8% of forecasted annual revenue but only 19.7% of forecasted operating income, implying substantial margin expansion required in remaining quarters. The sustainability of reported earnings is questionable without continued non-recurring gains. Second, working capital management has deteriorated to crisis levels with 621 days of inventory outstanding and 242 days of receivables collection, collectively creating a 623-day cash conversion cycle. This represents approximately 1.7 years of capital trapped in operating cycle versus industry norms of 150-270 days. The underlying cause requires investigation, whether due to channel inventory build-up, product acceptance issues, customer credit quality deterioration, or accounting recognition policies. Resolution of this inefficiency could release substantial capital while improving return metrics. Third, the capital allocation framework appears unsustainable with cash declining 53.6% to 12.5B yen while committing to 230 yen per share year-end dividend (approximately 7.9B yen payout). This creates a calculated payout ratio approaching 595% of quarterly net income, requiring either dramatic earnings improvement, reserve draws, or further asset monetization to fund. The dividend policy signals management confidence in business recovery or prioritization of shareholder returns, but sustainability depends entirely on working capital normalization and operational cash flow restoration in subsequent quarters.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.